Comparison of iPSC-derived human intestinal epithelial cells with Caco-2 cells and human in vivo data after exposure to Lactiplantibacillus plantarum WCFS1

Sci Rep. 2024 Nov 2;14(1):26464. doi: 10.1038/s41598-024-74802-w.

Abstract

To investigate intestinal health and its potential disruptors in vitro, representative models are required. Human induced pluripotent stem cell (hiPSC)-derived intestinal epithelial cells (IECs) more closely resemble the in vivo intestinal tissue than conventional in vitro models like human colonic adenocarcinoma Caco-2 cells. However, the potential of IECs to study immune-related responses upon external stimuli has not been investigated in detail yet. The aim of the current study was to evaluate immune-related effects of IECs by challenging them with a pro-inflammatory cytokine cocktail. Subsequently, the effects of Lactiplantibacillus plantarum WCFS1 were investigated in unchallenged and challenged IECs. All exposures were compared to Caco-2 cells and in vivo data where possible. Upon the inflammatory challenge, IECs and Caco-2 cells induced a pro-inflammatory response which was strongest in IECs. Heat-killed L. plantarum exerted the strongest effect on immune parameters in the IEC model, while L. plantarum in the stationary growth phase had most pronounced effects on immune-related gene expression in Caco-2 cells. Unfortunately, comparison to in vivo transcriptomics data showed limited similarities, which could be explained by essential differences in the study setups. Altogether, hiPSC-derived IECs show a high potential as a model to study immune-related responses in the intestinal epithelium in vitro.

Publication types

  • Comparative Study

MeSH terms

  • Caco-2 Cells
  • Cytokines / metabolism
  • Epithelial Cells / drug effects
  • Humans
  • Induced Pluripotent Stem Cells* / cytology
  • Intestinal Mucosa* / cytology
  • Intestinal Mucosa* / drug effects
  • Intestinal Mucosa* / immunology
  • Intestinal Mucosa* / microbiology
  • Lactobacillus plantarum

Substances

  • Cytokines

Grants and funding